Our Views - ADAMAS Consulting

Computer Software Assurance (CSA): Why the Change and What Does it Mean?

Date April 28, 2022

At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER)...

Read More

Annex 1 Revisions: What are the Changes and Whom will they Affect?

Date April 13, 2022

The EU has released a draft version of Annex 1. Expected to be implemented either later this year (2022) or early next year,...

Read More

Why Is Data Integrity Important When Transferring Data in a Clinical Trial?

Date March 28, 2022

This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”....

Read More

ADAMAS and Ergomed combine to expand global capabilities

February 9, 2022

I am delighted to share some exciting news released today about the acquisition of ADAMAS Consulting Group Limited by Ergomed plc which will allow...

ADAMAS Spotlight: Jean-Luc Salendre

Date January 18, 2022

The diversity of our people, in skills, background and experience, is what gives ADAMAS its strength and ability to conduct ourselves with excellence...

Read More

Top 6 Tips for Inspection Readiness

Date January 12, 2022

No matter if you're preparing for an imminent clinical trial inspection or if you're just bracing for a mock inspection, it is vital...

Read More

Load More You’ve reached the end of the list